Singapore markets closed
Straits Times Index
3,303.19 +10.26 (+0.31%) S&P 500
5,157.53 +29.74 (+0.58%) Dow
38,720.39 +44.71 (+0.12%) Nasdaq
16,276.94 +120.61 (+0.75%) Bitcoin USD
63,431.96 -842.68 (-1.31%) CMC Crypto 200
1,363.16 +50.54 (+3.85%)
PRTA Jan 2026 30.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:02AM EDT. Market open.
| Previous close | 12.50 |
| Open | 12.30 |
| Bid | 10.50 |
| Ask | 12.90 |
| Strike | 30.00 |
| Expiry date | 2026-01-16 |
| Day's range | 12.30 - 12.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 25 |
Business WireProthena to Report First Quarter 2024 Financial Results on May 8
DUBLIN, Ireland, May 01, 2024--Prothena announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.
ZacksEarnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline
Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireProthena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.
© 2024 Yahoo. All rights reserved.